{"schema_version":"secwatch.filing_event.v1","accession":"0000064803-23-000015","form_type":"8-K","ticker":"CVS","cik":"0000064803","company_name":"CVS HEALTH Corp","filed_at":"2023-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.930540+00:00","generated_at":"2026-06-16T01:54:12.291600+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CVS Health Q1 revenue up 11% to $85.3B; EPS falls; guidance cut; closes Signify & Oak Street","bullets":["Total revenues $85.3B (+11% YoY); GAAP diluted EPS $1.65 (down from $1.77); Adjusted EPS $2.20 (down from $2.30).","Full-year GAAP EPS guidance cut to $6.90-$7.12 from $7.73-$7.93; Adjusted EPS cut to $8.50-$8.70 from $8.70-$8.90.","Completed Signify Health acquisition ($7.8B) on Mar 29 and Oak Street Health ($10.6B) on May 2; total ~$18.4B.","Cash flow from operations $7.4B in Q1; reaffirmed full-year CF guidance $12.5-$13.5B.","Returned $779M to shareholders via dividends and repurchased 22.8M shares."],"urls":{"canonical":"https://secwatch.observer/filing/0000064803-23-000015","json":"https://secwatch.observer/filing/0000064803-23-000015.json","markdown":"https://secwatch.observer/filing/0000064803-23-000015.md","text":"https://secwatch.observer/filing/0000064803-23-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000015/0000064803-23-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000015/cvs-20230503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T01:54:12.291600+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"420749f8041756469b19dde3ea0a297e332b0b6a","claim":"CVS HEALTH Corp reported three months ended March 31, 2023 results: revenue $85,278. Guidance lowered.","evidence_excerpt":"Adjusted EPS of $2.20 • Generated cash flow from operations of $7.4 billion Three Months Ended March 31, In millions, except per share amounts 2023 2022 Change Total revenues $ 85,278 $ 76,826 $ 8,452 Operating income 3,446 3,545 (99) Adjusted operating income (1) 4,370 4,607 (237) Diluted earnings per share $ 1.65 $ 1.77 $ (0.12) Adjusted EPS (2) $ 2.20 $ 2.30","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480323000015/0000064803-23-000015-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2023"},{"label":"Revenue","value":"$85,278"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}